Current status of HTRF^® technology in kinase assays

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.3, Iss.12, 2008-12, pp. : 1461-1474

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status

By Kelland L.R.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 12, 2000-12 ,pp. : 2903-2911

Informa Healthcare

Access to resources Recommend Favorite

Current status of regenerative medical therapy based on drug delivery technology

By Tabata Yasuhiko

Reproductive BioMedicine Online, Vol. 16, Iss. 1, 2008-01 ,pp. : 70-80

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Transforming Viral Sequences to A (H1N1) Flu Diagnosis: The Current Status and Future Prospects of rtPCR Based Assays

Current Pharmaceutical Biotechnology, Vol. 11, Iss. 1, 2010-01 ,pp. : 113-116

Bentham Science Publishers

Access to resources Recommend Favorite

Biosimilars: Current Status

By Kuhlmann Martin K.

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 3, 2007-01 ,pp. : 199-206

Adis International

Access to resources Recommend Favorite

Chronopharmacokinetics: Current Status

By Bruguerolle B.

Clinical Pharmacokinetics, Vol. 35, Iss. 2, 1998-08 ,pp. : 83-94

Adis International

Access to resources Recommend Favorite